1. Kannell, W. B., Castelli, W. P., Gordon, T., McNamara, P. M.: Serum Cholesterol, lipoproteins, and the risk of coronary heart disease. Ann. Intern. Med.74, 1?12 (1971)
2. Nikkilä, E.: Studies on the lipoprotein relationships in normal and pathological sera and the effect of heparin on serum lipoproteins. Scand. J. Clin. Lab. Invest.5 [Suppl. 8], 1?101 (1953)
3. Lewis, B., Chait, A., Oakley, C. M. O., Wootton, I. D. P., Krikler, D. M., Onitiri, A., Sigurdsson, G., February, A.: Serum lipoprotein abnormalities in patients with ischaemic heart disease: Comparison with a control population. Br. Med. J.1974 III, 489?493
4. Castelli, W. P., Doyle, J. T., Gordon, T., Harnes, C., Hulley, S. B., Kagan, A., McGee, D., Vicic, W. J., Zukel, W. J.: HDL-Cholesterol levels in coronary heart disease: A co-operative lipoprotein phenotyping study. Circulation52 [Suppl. II], 97 (1975)
5. Rehoads, G. G., Gulbrandsen, C. L., Kagan, A.: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N. Engl. J. Med.294, 293?298 (1976)